Floatz logo

Humanized Cd7 Car-T Cells

Mixed Phenotype Acute Leukemia

The First Affiliated Hospital of Soochow UniversityCell therapyPhase 1/2Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
73/ 100

Competitive context

72 Active assets in the Mixed Phenotype Acute Leukemia cohort.

Asset / SponsorPhaseRating
Daunorubicin
St. Jude Children's Research Hospital
Phase 4BB
ETOPOSIDE
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 3BB
Cytosin-Arabinosid
Children's Oncology Group
Phase 4BB
METHOTREXATE
Children's Oncology Group
Phase 4BB
DEXAMETHASONE
St. Jude Children's Research Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Humanized Cd7 Car-T Cells is also rated in:

T-cell non-Hodgkin lymphomaDormant
CCC
Indicative ·
53 / 100
View asset →
T lymphoblastic leukemia/lymphomaDormant
CC
Indicative ·
47 / 100
View asset →
acute myeloid leukemiaDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →